Response to fluorescein angiography and OCT

Gallego-Pinazo, Roberto; Díaz-Llopis, M.; Dolz, R.; Martínez-Castillo, S.
March 2011
Graefe's Archive of Clinical & Experimental Ophthalmology;Mar2011, Vol. 249 Issue 3, p465
Academic Journal
No abstract available.


Related Articles

  • Fundus fluorescein angiography and OCT. Gupta, Deepak // Graefe's Archive of Clinical & Experimental Ophthalmology;Mar2011, Vol. 249 Issue 3, p463 

    No abstract available.

  • Direct photocoagulation to leakage points to treat chronic macular edema associated with branch retinal vein occlusion: a pilot study. Susumu Sakimoto; Motohiro Kamei; Hirokazu Sakaguchi; Mihoko Suzuki; Nagakazu Matsumura; Kentaro Nishida; Kohji Nishida // Clinical Ophthalmology;2014, Vol. 8, p2055 

    Summary statement: Direct photocoagulation reduces the central foveal thickness (CFT) in cases with chronic branch retinal vein occlusion (BRVO) of longer than 12 months duration. Photocoagulation might be effective for chronic macular edema due to branch retinal vein occlusion. Background: The...

  • Identification of ORT after anti-VEGF treatment for neovascular AMD critical.  // Ocular Surgery News;11/25/2014, Vol. 32 Issue 22, p34 

    The article reports on a study published in the journal "Ophthalmology" that reveals the importance of identification of eyes with outer retinal tubulations after anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.

  • Therapeutic Effect of Oral Bisphosphonates on Choroidal Neovascularization in the Human Eye. Honda, Shigeru; Nagai, Takayuki; Kondo, Naoshi; Fukuda, Masahide; Kusuhara, Sentaro; Tsukahara, Yasutomo; Negi, Akira // Journal of Ophthalmology;2010, p1 

    Purpose. Choroidal neovascularization (CNV) is often associated with age-related macular degeneration (AMD) and pathological myopia (PM). Bisphosphonates, the drug of choice to treat osteoporosis, have been recently reported to have anti-angiogenic effects. The purpose of this study is to...

  • Fluorescein angiography, optical coherence tomography, and histopathologic findings in a VEGF animal model of retinal angiogenesis. Arana, Luís; Pinto, Anderson; Chader, Gerald; Barbosa, Jose; Morales, Sabina; Moreira, Ana; Maia, Mauricio; Humayun, Mark // Graefe's Archive of Clinical & Experimental Ophthalmology;Oct2012, Vol. 250 Issue 10, p1421 

    Background: To establish an animal model of retinal neovascularization using vascular endothelial growth factor (VEGF165) and analyze the model using optical coherence tomography (OCT), fluorescein angiography (FA), and histopathologic evaluation. Methods: Twelve rabbits were divided into groups...

  • Real-world experience may guide intravitreal injection treatments. Dalton, Michelle; Moshfeghi, Andrew // Ophthalmology Times;Mar2015, Vol. 40 Issue 4, p32 

    The article discusses the use of steroid implants in the treatment of patients with diabetic macular edema (DME). Topics covered include the approval of intravitreal injection implants, Ozurdex or dexamethasone from pharmaceutical firm Allergan and fluocinolone acetonide or Iluvien from...

  • A guide to Age-related macular degeneration. Varma, Deepali // British Journal of Hospital Medicine (17508460);May2015, Vol. 76 Issue 5, p1 

    The article discusses age-related macular degeneration, a potentially blinding degenerative condition of the macula and is the leading cause of blindness among older people around the world. Topics discussed include the different kinds of age-related macular degeneration and their...

  • Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study. Adelman, Ron; Parnes, Aaron; Michalewska, Zofia; Parolini, Barbara; Boscher, Claude; Ducournau, Didier // BioMed Research International;1/28/2015, Vol. 2015, p1 

    Objective. To compare the efficacy of different therapies in the treatment of diabetic macular edema (DME). Design. Nonrandomized, multicenter clinical study. Participants. 86 retina specialists from 29 countries provided clinical information on 2,603 patients with macular edema including 870...

  • Anti-VEGF for the Management of Diabetic Macular Edema. Rosa Stefanini, Francisco; Badaró, Emmerson; Falabella, Paulo; Koss, Michael; Eid Farah, Michel; Maia, Maurício // Journal of Immunology Research;2014, p1 

    Diabetic retinopathy (DR) is an important cause of vision loss around the world, being the leading cause in the population between 20 and 60 years old. Among patients with DR, diabetic macular edema (DME) is the most frequent cause of vision impairment and represents a significant public health...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics